Big Changes in Today’s Global Wound Care Market

18 December 2019
Pharma

As one of today’s fastest-growing industries, the global wound care market certainly shows no signs of slowing down any time soon. Those armed with the right industry knowledge can make decisions to solidify their long-term success in the marketplace, which is why Visiongain is excited to share some of the big changes the industry is undergoing.

Here you’ll find out some of the things that can provide big opportunities for business owners and manufacturers in the wound care market.

Exciting Body Regenerative Solutions for Wound Care

One new and exciting change for the wound care market involves regenerative skincare solutions. Recently, biotech company BioLab Sciences has received numerous awards for its MyOwn Skin product, which provides a healing alternative to burn victims suffering from chronic, non-healing wounds. By using this innovative wound care technology, skin grafts are created from a small sample of the patient’s skin that minimizes the need for invasive removal of areas of healthy skin elsewhere on the patient’s body.

New Wound Care Applications for Fish Skin

Another exciting and groundbreaking wound care discovery comes from the company specializing in medical fish skin; Kerecis, who have pioneered new technology involving the use of fish skin in regenerative wound care. The new technology was introduced at this year’s Symposium on Advanced Wound Care held in October. The product, known as Kerecis Omega3 Wound, provides medical practitioners with fish skin that, when grafted on to human tissue, converts itself into living human tissue with the help of the human cells it recruits.

3M Acquires Wound Care firm Acelity

In the largest acquisition in 3M’s history, the company recently purchased wound care firm Acelity for a whopping $6.7 billion. This means manufacturers 3M are going to be expanding into the wound care dressing and therapy market and increasing their offerings in those sectors, which will likely affect market size in the coming years. One of their spokesmen said the recent purchase is in-line with their commitment of delivering comprehensive health care solutions for patients.

Let Visiongain help you get the most returns!

Above are just a few of the exciting new changes affecting the wound care market. If you want to be armed with the necessary insight to make the right decisions in the years ahead, Visiongain would love to hear from you. With more than 1,500 in-depth market reports spanning more than 18 market verticals, we can give you the tools you need to create long-term success in the wound care market. Contact us online today or call +44 (0) 20 7549 9987.

Recent News

Visiongain Publishes Single-Cell Analysis Market Report 2022-2032

The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.

26 May 2022

Read

Visiongain Publishes Ophthalmic Devices Market Report 2022-2032

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

19 April 2022

Read

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

13 April 2022

Read

Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

13 April 2022

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever